Developer of Prostate Cancer Treatments Is Sold

Cougar Biotechnology, a developer of several experimental compounds used to treat such cancers as prostate cancer, breast cancer, and melanoma, is set to be sold to Johnson and Johnson.

This likely won't mean a whole lot in the near future in terms of new prostate cancer treatments being released, but when a very large biotech company buys a smaller one it is often because the smaller company has some promising products in development.

Hopefully, this acquisition will result in broader and swifter prostate cancer treatment development.

Photo by Jeffrey Coolidge - Getty Images